The Canadian Consortium for the Investigation of Cannabinoids -Cannabinoids in Clinical Practice 2015
You may have seen the hashtags #CCIC or #CCIC2015 floating around Twitter today. March 26-27 marks the annual Cannabinoids in Clinical Practice Convention. Held past years in major cities such as Vancouver, Milan and Chicago, the convention focuses on presenting evidence-based education in the field of cannabinoids in clinical practice. Expert researchers in the field of medical marijuana will host this two day event and present updates from research findings, stakeholders, and Canadian physicians on the safe use and effectiveness of using marijuana in medical practice.
@TheCMCIA: OrganiGram’s booth at the @ccictweeter Cannabinoids in Clinical Practice conference in Toronto
The science behind the endocannabinoid system will be presented, as well as the risks, efficacy, and how to approach medical marijuana as an option for patients.
Some big names on the committee include:
Dr. Lynda Balneaves, RN, PhD.
Dr. Paul Daeninck, MD, MSc FRCPC.
Dr. Ruth Dubin, MD PhD FCFP, D.A.A.P.M., D.C.A.P.M.
Dr. Bernard Le Foll, MD PhD CCFP.
Dr. Mark A. Ware, MD MSc MBBS MRCP.
The conference is being held at the Sheraton Centre Toronto Hotel at 123 Queen Street West, Toronto, and will also exhibit a variety of licenced producers within Canada. The event will take place between 8am-5pm both days.
For more information please contact:
Daniel Ziemianski, Education Coordinator
Canadian Consortium for the Investigation of Cannabinoids
Tel: 514-934-1934 ext. 44362